DiaMedica Therapeutics Inc
Price
FilingsNewest: Form 10-Q, quarterly reportNov 12 →Insiders2 insiders bought $944,055 in 2 open-market buys. No sales.→HoldersCooperman Leon G 6.4%BlackRock 4.2%Geode 1.7%→Financing →PeersClosest companies: TNYA, COYA, DSGN→
From the filings
Figures
- Net income
- −$40.2Mlast 12 months
- Operating cash flow
- −$31.5Mlast 12 months
- Cash and equivalents
- $6.8Mat the last balance sheet
- Shares outstanding
- 54.0M shareson issue
Filings, newest first
- Nov 1210-QQuarterly report
- Nov 128-KResults of operations
- Aug 1010-QQuarterly report
- Aug 108-KResults of operations
- May 218-KShareholder vote
- May 610-QQuarterly report
- May 68-KResults of operations
- Mar 308-KResults of operations
- Mar 3010-KAnnual report
- Dec 8, 20254Insider trade
- Sep 4, 20254Insider trade